Viral vectors as vaccine platforms: from immunogenicity to impact
Viral vectors are the vaccine platform of choice for many pathogens that have thwarted efforts towards control using conventional vaccine approaches. Although the STEP trial encumbered development of recombinant human adenovirus vectors only a few years ago, replication-deficient simian adenoviruses...
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Journal article |
| Publicado em: |
Elsevier
2016
|